Receptors, Interleukin-8B
"Receptors, Interleukin-8B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
High-affinity G-protein-coupled receptors for INTERLEUKIN-8 present on NEUTROPHILS; MONOCYTES; and T-LYMPHOCYTES. These receptors also bind several other CXC CHEMOKINES.
Descriptor ID |
D023063
|
MeSH Number(s) |
D12.776.543.750.695.160.500.750.750 D12.776.543.750.705.852.125.500.750.750 D12.776.543.750.705.852.420.421.750
|
Concept/Terms |
Receptors, Interleukin-8B- Receptors, Interleukin-8B
- Receptors, Interleukin 8B
- Interleukin-8 Receptors Type B
- Interleukin 8 Receptors Type B
- Interleukin-8 Receptor Type B
- Interleukin 8 Receptor Type B
- Antigens, CDw128b
- Interleukin-8B Receptor
- Interleukin 8B Receptor
- Receptor, Interleukin-8B
- Receptors, CXCR2
- CXCR2 Receptors
- CXC Chemokine Receptor 2
- CDw128b Antigens
- Interleukin-8B Receptors
- Interleukin 8B Receptors
- CXCR2 Protein
- Interleukin-8 Receptors B
- Interleukin 8 Receptors B
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-8B".
- Chemicals and Drugs [D]
- Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
- Membrane Proteins [D12.776.543]
- Receptors, Cell Surface [D12.776.543.750]
- Receptors, G-Protein-Coupled [D12.776.543.750.695]
- Receptors, Chemokine [D12.776.543.750.695.160]
- Receptors, CXCR [D12.776.543.750.695.160.500]
- Receptors, Interleukin-8 [D12.776.543.750.695.160.500.750]
- Receptors, Interleukin-8B [D12.776.543.750.695.160.500.750.750]
- Receptors, Immunologic [D12.776.543.750.705]
- Receptors, Cytokine [D12.776.543.750.705.852]
- Receptors, Chemokine [D12.776.543.750.705.852.125]
- Receptors, CXCR [D12.776.543.750.705.852.125.500]
- Receptors, Interleukin-8 [D12.776.543.750.705.852.125.500.750]
- Receptors, Interleukin-8B [D12.776.543.750.705.852.125.500.750.750]
- Receptors, Interleukin [D12.776.543.750.705.852.420]
- Receptors, Interleukin-8 [D12.776.543.750.705.852.420.421]
- Receptors, Interleukin-8B [D12.776.543.750.705.852.420.421.750]
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-8B".
This graph shows the total number of publications written about "Receptors, Interleukin-8B" by people in this website by year, and whether "Receptors, Interleukin-8B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 0 | 1 | 1 |
2013 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
2020 | 1 | 1 | 2 |
2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, Interleukin-8B" by people in Profiles.
-
Targeting CXCR1/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients. Am J Transplant. 2021 11; 21(11):3714-3724.
-
AhR Activation Leads to Alterations in the Gut Microbiome with Consequent Effect on Induction of Myeloid Derived Suppressor Cells in a CXCR2-Dependent Manner. Int J Mol Sci. 2020 Dec 17; 21(24).
-
Epigenetic therapy inhibits metastases by disrupting premetastatic niches. Nature. 2020 03; 579(7798):284-290.
-
AhR Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Immunosuppressive Activity through Regulation of CXCR2 and MicroRNA miR-150-5p and miR-543-3p That Target Anti-Inflammatory Genes. J Immunol. 2019 10 01; 203(7):1830-1844.
-
MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target. Eur J Immunol. 2018 06; 48(6):1059-1073.
-
Role of inflammation and inflammatory mediators in colorectal cancer. Trans Am Clin Climatol Assoc. 2014; 125:358-72; discussion 372-3.
-
CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell. 2013 Nov 11; 24(5):631-44.
-
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med. 2006 Apr 17; 203(4):941-51.